AWHL Aspira Women's Health Inc.

NEUTRAL Impact: 3/10 8-K
Horizon weeks Filed Apr 30, 2026 Processed 1mo ago SEC 0000926617-26-000029
8-K context-dependent: Items 5.02
Latest settled — T+20d
AWHL ▲ +38.46% at T+20d
NEUTRAL call ✓ call won +38.46% · α vs SPY +33.20% · entry $0.3900 → $0.5400
Next anchor: T+60d in 6w
Last close $0.4800 (close Jun 12) · +23.08% from $0.3900 entry
Entry anchored
Apr 30, 2026
via day open
T+1d
-7.69%
call -7.69% · α -7.35%
$0.3600
settled 6w ago
T+5d
+10.26%
call +10.26% · α +7.91%
$0.4300
settled 6w ago
T+20d
+38.46%
call +38.46% · α +33.20%
$0.5400
settled 17d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Aspira Women's Health appointed John Strahley as CFO/CAO effective April 27, 2026, replacing Brian Hungerford who departed for personal reasons. The new CFO will work part-time (20 hrs/week) with a $167K salary and option grant, reflecting cost-consciousness amid a proxy contest context.

Actionable Insight

The fractional CFO role and low cash compensation signal ongoing cash conservation. Monitor for proxy fight outcomes and Q2 2026 financials to assess if cost cuts are sufficient.

Key Facts

  • John Strahley appointed CFO/CAO effective April 27, 2026
  • Prior CFO Brian Hungerford left voluntarily (personal reasons)
  • Strahley works fractional capacity: minimum 20 hours/week
  • Annual base salary of $167,000, no health/dental/vision benefits
  • Options to purchase 70,000 shares: 25% vest after 90 days, remainder over 9 months
  • DEFA14A filed 2 days prior indicates active proxy contest

Financial Impact

New CFO compensation disclosed: $167,000 annual salary plus 70,000 options; no material change to financials.

executive compensationshare-based compensation

Risk Factors

  • Part-time CFO may strain financial oversight during proxy contest
  • Potential further management turnover given governance instability
  • No severance could make retention of new CFO less certain

Market Snapshot

Exchange
OTC
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
80% bullish (5 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000926617-26-000029
Document: 0000926617-26-000029-index-headers.html0000926617-26-000029
Document: 0000926617-26-000029-index.html0000926617-26-000029
Document: 0000926617-26-000029.txt0000926617-26-000029
5 reports for AWHL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AWHL — sortable, filterable
Type Now
Jun 9, 2026
5d ago
8-K
BEARISH ★ 6/10
$0.4341 awaiting T+5awaiting T+5$0.4800 (−10.57%)
May 29, 2026
16d ago
Insider Cluster
BULLISH ★ 5/10
$0.5400 $0.4200▼ −22.22%▼ −19.47%$0.4800 (−11.11%)
May 26, 2026
19d ago
8-K
NEUTRAL ★ 4/10
$0.4600 $0.5400▲ +17.39%▲ +16.31%$0.4800 (+4.35%)
Apr 30, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$0.3900 $0.4300▲ +10.26%▲ +7.91%$0.4800 (+23.08%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 3/10
$0.4000 $0.3900▼ −2.50%▼ −5.61%$0.4800 (+20.00%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 4h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access